Neurometabolic Diseases Laboratory, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospital Duran i Reynals, L'Hospitalet de Llobregat, Spain.
Neurometabolic Diseases Laboratory, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospital Duran i Reynals, L'Hospitalet de Llobregat, Spain; CIBERER U759, Center for Biomedical Research on Rare Diseases, Spain.
Free Radic Biol Med. 2020 May 20;152:797-809. doi: 10.1016/j.freeradbiomed.2020.01.177. Epub 2020 Feb 1.
Adrenoleukodystrophy is a neurometabolic disorder caused by a defective peroxisomal ABCD1 transporter of very long-chain fatty acids (VLCFAs). Its pathogenesis is incompletely understood. Here we characterize a nematode model of X-ALD with loss of the pmp-4 gene, the worm orthologue of ABCD1. These mutants recapitulate the hallmarks of X-ALD: i) VLCFAs accumulation and impaired mitochondrial redox homeostasis and ii) axonal damage coupled to locomotor dysfunction. Furthermore, we identify a novel role for PMP-4 in modulating lipid droplet dynamics. Importantly, we show that the mitochondria targeted antioxidant MitoQ normalizes lipid droplets size, and prevents axonal degeneration and locomotor disability, highlighting its therapeutic potential. Moreover, PMP-4 acting solely in the hypodermis rescues axonal and locomotion abnormalities, suggesting a myelin-like role for the hypodermis in providing essential peroxisomal functions for the nematode nervous system.
肾上腺脑白质营养不良是一种神经代谢紊乱,由极长链脂肪酸(VLCFAs)的缺陷过氧化物酶体 ABCD1 转运蛋白引起。其发病机制尚不完全清楚。在这里,我们描述了一种 pmp-4 基因缺失的 X-ALD 线虫模型,pmp-4 是 ABCD1 的线虫同源物。这些突变体再现了 X-ALD 的特征:i)VLCFAs 积累和线粒体氧化还原稳态受损,以及 ii)轴突损伤与运动功能障碍相关。此外,我们确定了 PMP-4 在调节脂滴动力学中的新作用。重要的是,我们表明,靶向线粒体的抗氧化剂 MitoQ 可使脂滴大小正常化,并防止轴突退化和运动障碍,突出了其治疗潜力。此外,仅在真皮层发挥作用的 PMP-4 可挽救轴突和运动异常,这表明真皮层在为线虫神经系统提供必需的过氧化物酶体功能方面具有类髓鞘作用。